SCHEMBL24010757

SCHEMBL24010757

CNC[C@H](C)CNC1CCCC1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.48
ANPEP P15144 2/20 0.39
ERAP2 Q6P179 2/20 0.39
HTT P42858 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
LMNA P02545 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
SCN1A P35498 1/20 0.37
SCN2A Q99250 1/20 0.37
SCN3A Q9NY46 1/20 0.37
EPHX1 P07099 1/20 0.35
ALDH1A1 P00352 1/20 0.33
MCHR1 Q99705 2/20 0.32
ADRB2 P07550 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9407491 0.89 KDM4E (0.60) KDM4EANPEPERAP2HTTSMN1; SMN2
SCHEMBL9407497 0.81 KDM4E (0.52) KDM4EANPEPERAP2HTTSMN1; SMN2
SCHEMBL20635257 0.80 KDM4E (0.42) KDM4EANPEPERAP2HTTSMN1; SMN2
SCHEMBL7775034 0.80 KDM4E (0.50) KDM4EANPEPERAP2HTTSMN1; SMN2
SCHEMBL172662 0.79 KDM4E (0.58) KDM4EANPEPERAP2HTTSMN1; SMN2
SCHEMBL14612175 0.78 KDM4E (0.54) KDM4EANPEPERAP2HTTSMN1; SMN2
SCHEMBL15108080 0.78 KDM4E (0.48) KDM4EANPEPERAP2HTTSMN1; SMN2
SCHEMBL7770658 0.78 KDM4E (0.54) KDM4EANPEPERAP2HTTSMN1; SMN2
SCHEMBL7775262 0.78 KDM4E (0.54) KDM4EANPEPERAP2HTTSMN1; SMN2
SCHEMBL28834995 0.77 KDM4E (0.52) KDM4EANPEPERAP2HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021226629-A1 HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS AND METHODS OF USE AMGEN INC. (US) 2021-11-11 WO disclosed